‘100 new faces of Kazakhstan’ project: Zarina Sautbayeva

Zarina Sautbayeva is one of the winners of the ‘100 New Faces of Kazakhstan’ project. The young biomedical researcher was awarded the International Cancer Technology Transfer Fellowship by the Union for International Cancer Control. She studied in the leading medical schools of the world, focusing on the treatment of cancer. She is currently working in this area. The young specialist returned to Kazakhstan to use her experience in practice and share her knowledge with young researchers at Nazarbayev University.


- First, I was learning how to operate a cytometer in the city of Basel in Switzerland, where I studied cell biology. Then, I went to Boston to learn operating the ImageStream machine in Harvard Medical School. After that, I won a fellowship of the Union for International Cancer Control and went to study in Harvard. I was there three times and I studied at the expense of the fellowship that I won. We were involved in a small project there.   

Instructor of Nazarbayev University, Zarina Sautbayeva together with a group of other researchers is working on the colorectal cancer diagnosis, or bowel and colon cancer. It is one of the most common types of cancer. According to the project winner, the treatment success greatly depends on the early detection of the disease.


- We are currently studying the micro particles discharged by the colorectal cancer patients. We want to use them as potential biomarkers. These micro particles may be used for early cancer diagnosis, for prediction of the course of the disease and for monitoring the growth rate of the tumor. This study also provides a possibility of tracking the success of the therapy. We didn’t work this way before, but we can use this study in the future.  

Science is actively developing in Kazakhstan. Zarina Sautbayeva is one of those who initiated the global scientific researches in the country. She believes that the advanced technologies combined with knowledge and faith will help defeat the deadly disease.